Gerresheimer (GRRMF) to Announce Quarterly Earnings on Wednesday

by · The Markets Daily

Gerresheimer (OTCMKTS:GRRMF – Get Free Report) will likely be issuing its results before the market opens on Wednesday, September 16th. Analysts expect the company to announce earnings of $0.2854 per share and revenue of $694.4810 million for the quarter.

Gerresheimer Stock Performance

GRRMF stock opened at $32.20 on Monday. The stock has a 50-day moving average price of $31.80 and a two-hundred day moving average price of $28.04. Gerresheimer has a 1 year low of $19.16 and a 1 year high of $33.35.

Analysts Set New Price Targets

GRRMF has been the subject of a number of analyst reports. Jefferies Financial Group downgraded Gerresheimer to a “hold” rating in a research note on Monday, May 18th. UBS Group raised Gerresheimer from a “sell” rating to a “neutral” rating in a report on Tuesday, August 4th. Sanford C. Bernstein raised shares of Gerresheimer from an “underperform” rating to a “market perform” rating in a research note on Wednesday, July 1st. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Gerresheimer in a research note on Tuesday, August 4th. Four investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Gerresheimer presently has an average rating of “Reduce”.

Read Our Latest Stock Analysis on GRRMF

Gerresheimer Company Profile

(Get Free Report)

Gerresheimer AG is a Germany-based healthcare company that develops and manufactures specialty packaging and drug-delivery systems for the pharmaceutical, biotech and cosmetics industries. Its products are designed to protect, store and administer medicines and other sensitive healthcare products.

The company’s portfolio includes glass and plastic containers such as vials, ampoules, bottles and syringes, as well as prefillable syringes, cartridges, inhalers, injection pens and other delivery devices.

Further Reading